Follow
Biomarker Discovery
Biomarker Discovery is a process in which molecular substances in the body are used to indicate health or disease. One of the biggest challenges in biomarker discovery is the difficulty of identifying medium to low abundance proteins in complex biological samples.
What's Popular in Biomarker Discovery
-
JUN 17, 2025Clinical & Molecular DX
Several new studies have identified biomarkers of long COVID, which can tell us more about what causes the disease...Written By: Carmen LeitchAPR 15, 2025Clinical & Molecular DX
Scleroderma, or systemic sclerosis refers to a disorder in which the skin and connective tissues of the body start to th ...Written By: Carmen LeitchMAR 17, 2025Clinical & Molecular DX
Scientists and clinicians have long sought biomarkers that can reveal biological age, and the mechanisms that drive agin ...Written By: Carmen LeitchFEB 18, 2025Clinical & Molecular DX
It's estimated that around 13.4 million infants are born prematurely around the world, and preterm north complicatio ...Written By: Carmen LeitchJAN 31, 2025Clinical & Molecular DX
Researchers have identified two biomarkers that can reveal how sensitive an individual is to pain, and may offer new app ...Written By: Carmen Leitch
JUN 17, 2025
Clinical & Molecular DX
Several new studies have identified biomarkers of long COVID, which can tell us more about what causes the disease...
Written By:
Carmen Leitch
APR 15, 2025
Clinical & Molecular DX
Scleroderma, or systemic sclerosis refers to a disorder in which the skin and connective tissues of the body start to th
...
Written By:
Carmen Leitch
MAR 17, 2025
Clinical & Molecular DX
Scientists and clinicians have long sought biomarkers that can reveal biological age, and the mechanisms that drive agin
...
Written By:
Carmen Leitch
FEB 18, 2025
Clinical & Molecular DX
It's estimated that around 13.4 million infants are born prematurely around the world, and preterm north complicatio
...
Written By:
Carmen Leitch
JAN 31, 2025
Clinical & Molecular DX
Researchers have identified two biomarkers that can reveal how sensitive an individual is to pain, and may offer new app
...
Written By:
Carmen Leitch
JAN 03, 2025
Clinical & Molecular DX
Detecting changes in the brain can be very difficult. Scientists have now developed a kind of molecular flashlight that
...
Written By:
Carmen Leitch
DEC 23, 2024
Clinical & Molecular DX
Scientists believe that Alzheimer's disease develops over decades, but it is usually not diagnosed until well after
...
Written By:
Carmen Leitch
DEC 03, 2024
Immunology
Join us to explore the latest insights into the future of precision oncology! This year, the Agilent Precision Oncology
...
NOV 28, 2024
Clinical & Molecular DX
The definition of psychosis is loose. The NIMH states that psychosis consists of "a collection of symptoms that affect t
...
Written By:
Carmen Leitch
-
NOV 18, 2025 | 8:00 AM
Transcriptomics represents a critical discipline in cancer research, enabling comprehensive mapping of gene expression profiles and the identification of fusion genes implicated in tumor dev...NOV 20, 2025 | 8:00 AM
Uveal melanoma (UM) is the most common primary intraocular cancer in adults, with up to 50% of patients developing fatal metastases. Current prognostic tests rely on tumor tissue obtained th...DEC 02, 2025 | 8:00 AM
Parkinson’s disease (PD) remains one of the most challenging neurodegenerative disorders to diagnose and monitor. Conventional clinical assessments and imaging often miss the early mol...DEC 10, 2025 | 2:00 PM
Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in Europe and the U.S.—yet when detected early, the 5-year survival rate jumps to 91% . While colonoscopy r...DEC 10, 2025 | 8:00 AM
Mass spectrometry (MS)-based proteomic biomarker discovery pipeline commonly begins with large-scale profiling techniques detecting thousands of candidate biomarkers. Efficiently triaging th...
NOV 18, 2025 | 8:00 AM
Transcriptomics represents a critical discipline in cancer research, enabling comprehensive mapping of gene expression profiles and the identification of fusion genes implicated in tumor dev...
NOV 20, 2025 | 8:00 AM
Uveal melanoma (UM) is the most common primary intraocular cancer in adults, with up to 50% of patients developing fatal metastases. Current prognostic tests rely on tumor tissue obtained th...
DEC 02, 2025 | 8:00 AM
Parkinson’s disease (PD) remains one of the most challenging neurodegenerative disorders to diagnose and monitor. Conventional clinical assessments and imaging often miss the early mol...
DEC 10, 2025 | 2:00 PM
Colorectal cancer (CRC) is the second-leading cause of cancer-related deaths in Europe and the U.S.—yet when detected early, the 5-year survival rate jumps to 91% . While colonoscopy r...
DEC 10, 2025 | 8:00 AM
Mass spectrometry (MS)-based proteomic biomarker discovery pipeline commonly begins with large-scale profiling techniques detecting thousands of candidate biomarkers. Efficiently triaging th...
OCT 28, 2025 | 7:00 AM
C.E. CREDITS
In recognition of Breast Cancer Awareness Month, join us for a live webinar to uncover the complexity of tumor biology and the surprising resilience of normal tissue. This event will feature...
Speaker:
Alison Cheung, PhD
, Colinda Scheele, PhD
, Andrea Radtke, PhD
Sponsored By: Leica Microsystems
OCT 21, 2025 | 9:00 AM
Plasma proteomics offers great promise for biomarker discovery, due to the accessibility and diagnostic relevance of blood plasma. Recent advances in instrumentation, particularly the Orbitr...
OCT 01, 2025 | 9:00 AM
Our experience collaborating with oncology and immunology leaders in the pharmaceutical and biotech space has revealed the numerous challenges in every stage of drug development. From target...
Speaker:
Sathiya Manivannan
SEP 17, 2025 | 8:00 AM
Seer’s novel approach to mass spectrometry-based proteomics can reveal layers of biological information invisible to other methods, offering the potential for transformative insights....
-
Announcing xMAP® Connect 2025 Virtual Webinar Series Join us for an immersive virtual experience about Multiplexing - From Data to Discovery - starting Wednesday, October 1st, with webin...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Event in the Drug Discovery & Development...
Labroots is excited to announce our 14th Annual Precision Medicine: Genomics, Genetics & Molecular Diagnostics Virtual Event Series 2026 held on April 29th, 2026! The Precision Medicine:...
Labroots invites you to the 9 th Annual Event in the CRISPR Virtual Event Series 2026 taking place on October 28th, 2026! This event will continue the conversation of the abilities of CRISPR...OCT 22, 2025 | 5:30 AM PDTC.E. CREDITS
Labroots invites you to the 8 th Annual Event in the CRISPR Virtual Event Series 2025 taking place on October 22nd, 2025! This event will continue the conversation of the abilities of CRISPR...
Announcing xMAP® Connect 2025 Virtual Webinar Series Join us for an immersive virtual experience about Multiplexing - From Data to Discovery - starting Wednesday, October 1st, with webin...
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 9th Annual Event in the Drug Discovery & Development...
Labroots is excited to announce our 14th Annual Precision Medicine: Genomics, Genetics & Molecular Diagnostics Virtual Event Series 2026 held on April 29th, 2026! The Precision Medicine:...
Labroots invites you to the 9 th Annual Event in the CRISPR Virtual Event Series 2026 taking place on October 28th, 2026! This event will continue the conversation of the abilities of CRISPR...
OCT 22, 2025
| 5:30 AM PDT
C.E. CREDITS
Labroots invites you to the 8 th Annual Event in the CRISPR Virtual Event Series 2025 taking place on October 22nd, 2025! This event will continue the conversation of the abilities of CRISPR...
OCT 08, 2025
| 8:00 AM PDT
Join us at the Olink Proteomics Conference , a novel platform for scientists exploring the latest advancements in proteomics and proteogenomics on immunology, oncology, neuroscience, ageing,...
JUN 05, 2025
| 10:00 AM PDT
Single-cell sequencing has revolutionized the ability of scientists to understand disease mechanisms by revealing heterogeneity within organs and tissues. Now, recent studies are beginning t...
MAY 14, 2025
| 5:30 AM PDT
C.E. CREDITS
Labroots is excited to announce our 13th Annual Precision Medicine: Genomics, Genetics & Molecular Diagnostics Virtual Event Series 2025 held on May 14th, 2025! The Precision Medicine: G...
FEB 19, 2025
| 6:00 AM PST
C.E. CREDITS
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 8 th Annual Event in the Drug Discovery & Development...